Trial
NCT04479358
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
COVID-19
Intervention
Tocilizumab
Why stopped
Lack of recruitment of patients into the trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-08